nodes	percent_of_prediction	percent_of_DWPC	metapath
Niacin—QPRT—head—thyroid cancer	0.0183	0.133	CbGeAlD
Niacin—NNMT—saliva-secreting gland—thyroid cancer	0.0159	0.116	CbGeAlD
Niacin—NNMT—trachea—thyroid cancer	0.0123	0.0895	CbGeAlD
Niacin—HCAR2—lymph node—thyroid cancer	0.0107	0.0782	CbGeAlD
Niacin—NNMT—thyroid gland—thyroid cancer	0.00973	0.0708	CbGeAlD
Niacin—NNMT—head—thyroid cancer	0.00863	0.0628	CbGeAlD
Niacin—SLC16A3—trachea—thyroid cancer	0.0084	0.0611	CbGeAlD
Niacin—SLC16A3—thyroid gland—thyroid cancer	0.00664	0.0484	CbGeAlD
Niacin—SLC16A3—The citric acid (TCA) cycle and respiratory electron transport—NDUFA13—thyroid cancer	0.00658	0.0189	CbGpPWpGaD
Niacin—SLC5A8—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC5A5—thyroid cancer	0.00622	0.0179	CbGpPWpGaD
Niacin—NNMT—lymph node—thyroid cancer	0.00604	0.044	CbGeAlD
Niacin—SLC16A3—head—thyroid cancer	0.00589	0.0429	CbGeAlD
Niacin—SLCO2B1—Farnesoid X Receptor  Pathway—RXRA—thyroid cancer	0.00562	0.0162	CbGpPWpGaD
Niacin—HCAR2—GPCR ligand binding—CALCB—thyroid cancer	0.00495	0.0143	CbGpPWpGaD
Niacin—HCAR3—GPCR ligand binding—CALCB—thyroid cancer	0.00469	0.0135	CbGpPWpGaD
Niacin—SLC16A3—Pyruvate metabolism and Citric Acid (TCA) cycle—RXRA—thyroid cancer	0.00464	0.0134	CbGpPWpGaD
Niacin—SLC5A8—NRF2 pathway—SLC5A5—thyroid cancer	0.00441	0.0127	CbGpPWpGaD
Niacin—SLC16A1—Pyruvate metabolism—RXRA—thyroid cancer	0.00414	0.0119	CbGpPWpGaD
Niacin—SLC16A3—lymph node—thyroid cancer	0.00413	0.0301	CbGeAlD
Niacin—SLC16A1—thyroid gland—thyroid cancer	0.00404	0.0294	CbGeAlD
Niacin—SLC16A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—CP—thyroid cancer	0.00399	0.0115	CbGpPWpGaD
Niacin—SLC22A5—saliva-secreting gland—thyroid cancer	0.00378	0.0275	CbGeAlD
Niacin—SLC5A8—SLC-mediated transmembrane transport—TPR—thyroid cancer	0.00371	0.0107	CbGpPWpGaD
Niacin—SLC5A8—SLC-mediated transmembrane transport—CP—thyroid cancer	0.00371	0.0107	CbGpPWpGaD
Niacin—SLC5A8—NRF2 pathway—RXRA—thyroid cancer	0.00371	0.0107	CbGpPWpGaD
Niacin—SLC16A1—head—thyroid cancer	0.00358	0.0261	CbGeAlD
Niacin—SLC16A1—The citric acid (TCA) cycle and respiratory electron transport—NDUFA13—thyroid cancer	0.00355	0.0102	CbGpPWpGaD
Niacin—SLCO2B1—thyroid gland—thyroid cancer	0.00347	0.0253	CbGeAlD
Niacin—NNMT—Biological oxidations—RXRA—thyroid cancer	0.00325	0.00936	CbGpPWpGaD
Niacin—SLC5A8—NRF2 pathway—NRG1—thyroid cancer	0.00321	0.00923	CbGpPWpGaD
Niacin—SLCO2B1—head—thyroid cancer	0.00308	0.0224	CbGeAlD
Niacin—HCAR2—Class A/1 (Rhodopsin-like receptors)—TSHR—thyroid cancer	0.00301	0.00867	CbGpPWpGaD
Niacin—QPRT—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—thyroid cancer	0.003	0.00863	CbGpPWpGaD
Niacin—HCAR2—G alpha (i) signalling events—SST—thyroid cancer	0.00294	0.00848	CbGpPWpGaD
Niacin—SLC22A5—trachea—thyroid cancer	0.00291	0.0212	CbGeAlD
Niacin—HCAR3—Class A/1 (Rhodopsin-like receptors)—TSHR—thyroid cancer	0.00285	0.00822	CbGpPWpGaD
Niacin—HCAR2—GPCR downstream signaling—CALCB—thyroid cancer	0.0028	0.00806	CbGpPWpGaD
Niacin—HCAR3—G alpha (i) signalling events—SST—thyroid cancer	0.00279	0.00804	CbGpPWpGaD
Niacin—SLC5A8—SLC-mediated transmembrane transport—SLC5A5—thyroid cancer	0.00278	0.00801	CbGpPWpGaD
Niacin—HCAR3—GPCR downstream signaling—CALCB—thyroid cancer	0.00265	0.00764	CbGpPWpGaD
Niacin—QPRT—Disease—TRIM24—thyroid cancer	0.00261	0.00751	CbGpPWpGaD
Niacin—QPRT—Metabolism—MINPP1—thyroid cancer	0.00257	0.0074	CbGpPWpGaD
Niacin—HCAR2—Signaling by GPCR—CALCB—thyroid cancer	0.00254	0.00732	CbGpPWpGaD
Niacin—SLC16A1—lymph node—thyroid cancer	0.00251	0.0183	CbGeAlD
Niacin—SLC16A1—Pyruvate metabolism and Citric Acid (TCA) cycle—RXRA—thyroid cancer	0.00251	0.00722	CbGpPWpGaD
Niacin—QPRT—Disease—CHST14—thyroid cancer	0.00245	0.00706	CbGpPWpGaD
Niacin—HCAR3—Signaling by GPCR—CALCB—thyroid cancer	0.00241	0.00694	CbGpPWpGaD
Niacin—NNMT—Metabolism—MINPP1—thyroid cancer	0.00239	0.00688	CbGpPWpGaD
Niacin—HCAR2—Class A/1 (Rhodopsin-like receptors)—SST—thyroid cancer	0.00234	0.00674	CbGpPWpGaD
Niacin—QPRT—Disease—TRIM33—thyroid cancer	0.00233	0.00669	CbGpPWpGaD
Niacin—SLC22A5—thyroid gland—thyroid cancer	0.00231	0.0168	CbGeAlD
Niacin—HCAR2—GPCR ligand binding—TSHR—thyroid cancer	0.00229	0.0066	CbGpPWpGaD
Niacin—HCAR3—Class A/1 (Rhodopsin-like receptors)—SST—thyroid cancer	0.00222	0.00639	CbGpPWpGaD
Niacin—QPRT—Metabolism—NDUFA13—thyroid cancer	0.00218	0.00629	CbGpPWpGaD
Niacin—HCAR3—GPCR ligand binding—TSHR—thyroid cancer	0.00217	0.00626	CbGpPWpGaD
Niacin—SLCO2B1—lymph node—thyroid cancer	0.00216	0.0157	CbGeAlD
Niacin—SLC16A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—CP—thyroid cancer	0.00216	0.00621	CbGpPWpGaD
Niacin—QPRT—Metabolism—CHST14—thyroid cancer	0.00205	0.00591	CbGpPWpGaD
Niacin—NNMT—Metabolism—NDUFA13—thyroid cancer	0.00203	0.00585	CbGpPWpGaD
Niacin—HCAR2—GPCR ligand binding—PTCH1—thyroid cancer	0.00195	0.00561	CbGpPWpGaD
Niacin—NNMT—Metabolism—CHST14—thyroid cancer	0.00191	0.0055	CbGpPWpGaD
Niacin—SLC5A8—Transmembrane transport of small molecules—TPR—thyroid cancer	0.00189	0.00543	CbGpPWpGaD
Niacin—SLC5A8—Transmembrane transport of small molecules—CP—thyroid cancer	0.00189	0.00543	CbGpPWpGaD
Niacin—SLC5A8—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	0.00186	0.00535	CbGpPWpGaD
Niacin—SLC22A5—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—CP—thyroid cancer	0.00185	0.00534	CbGpPWpGaD
Niacin—HCAR3—GPCR ligand binding—PTCH1—thyroid cancer	0.00185	0.00532	CbGpPWpGaD
Niacin—SLC16A3—SLC-mediated transmembrane transport—TPR—thyroid cancer	0.00181	0.00522	CbGpPWpGaD
Niacin—SLC16A3—SLC-mediated transmembrane transport—CP—thyroid cancer	0.00181	0.00522	CbGpPWpGaD
Niacin—SLC16A3—The citric acid (TCA) cycle and respiratory electron transport—RXRA—thyroid cancer	0.0018	0.00518	CbGpPWpGaD
Niacin—HCAR2—GPCR ligand binding—SST—thyroid cancer	0.00178	0.00513	CbGpPWpGaD
Niacin—HCAR2—GPCR ligand binding—CALCA—thyroid cancer	0.00172	0.00494	CbGpPWpGaD
Niacin—HCAR3—GPCR ligand binding—SST—thyroid cancer	0.00169	0.00487	CbGpPWpGaD
Niacin—QPRT—Metabolism—HPGD—thyroid cancer	0.00166	0.00477	CbGpPWpGaD
Niacin—HCAR3—GPCR ligand binding—CALCA—thyroid cancer	0.00163	0.00468	CbGpPWpGaD
Niacin—QPRT—Disease—TCF7L1—thyroid cancer	0.00155	0.00447	CbGpPWpGaD
Niacin—NNMT—Metabolism—HPGD—thyroid cancer	0.00154	0.00443	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—CALCB—thyroid cancer	0.0015	0.00432	CbGpPWpGaD
Niacin—Erythema—Sorafenib—thyroid cancer	0.00148	0.00288	CcSEcCtD
Niacin—Feeling hot—Doxorubicin—thyroid cancer	0.00148	0.00287	CcSEcCtD
Niacin—Necrosis—Doxorubicin—thyroid cancer	0.00148	0.00287	CcSEcCtD
Niacin—Gastrointestinal pain—Vandetanib—thyroid cancer	0.00147	0.00285	CcSEcCtD
Niacin—Rash pustular—Doxorubicin—thyroid cancer	0.00145	0.00282	CcSEcCtD
Niacin—Breast pain—Epirubicin—thyroid cancer	0.00144	0.00279	CcSEcCtD
Niacin—SLC22A5—lymph node—thyroid cancer	0.00143	0.0104	CbGeAlD
Niacin—Jaundice cholestatic—Epirubicin—thyroid cancer	0.00143	0.00277	CcSEcCtD
Niacin—Muscle spasms—Sorafenib—thyroid cancer	0.00143	0.00277	CcSEcCtD
Niacin—HCAR3—Signaling Pathways—CALCB—thyroid cancer	0.00142	0.0041	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—TRIM33—thyroid cancer	0.00142	0.0041	CbGpPWpGaD
Niacin—Abdominal pain—Vandetanib—thyroid cancer	0.00142	0.00275	CcSEcCtD
Niacin—Body temperature increased—Vandetanib—thyroid cancer	0.00142	0.00275	CcSEcCtD
Niacin—SLC5A8—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	0.00141	0.00407	CbGpPWpGaD
Niacin—Bone disorder—Epirubicin—thyroid cancer	0.00139	0.00269	CcSEcCtD
Niacin—Skin discolouration—Epirubicin—thyroid cancer	0.00139	0.00269	CcSEcCtD
Niacin—Hyperbilirubinaemia—Epirubicin—thyroid cancer	0.00138	0.00268	CcSEcCtD
Niacin—Cough increased—Epirubicin—thyroid cancer	0.00137	0.00266	CcSEcCtD
Niacin—SLC16A3—SLC-mediated transmembrane transport—SLC5A5—thyroid cancer	0.00136	0.00391	CbGpPWpGaD
Niacin—Angioedema—Sorafenib—thyroid cancer	0.00136	0.00263	CcSEcCtD
Niacin—Hyperuricaemia—Epirubicin—thyroid cancer	0.00135	0.00262	CcSEcCtD
Niacin—HCAR3—Signaling Pathways—TRIM33—thyroid cancer	0.00135	0.00388	CbGpPWpGaD
Niacin—Syncope—Sorafenib—thyroid cancer	0.00133	0.00258	CcSEcCtD
Niacin—Breast pain—Doxorubicin—thyroid cancer	0.00133	0.00258	CcSEcCtD
Niacin—Leukopenia—Sorafenib—thyroid cancer	0.00133	0.00258	CcSEcCtD
Niacin—Jaundice cholestatic—Doxorubicin—thyroid cancer	0.00132	0.00256	CcSEcCtD
Niacin—CYP2D6—head—thyroid cancer	0.00132	0.00961	CbGeAlD
Niacin—Loss of consciousness—Sorafenib—thyroid cancer	0.0013	0.00253	CcSEcCtD
Niacin—HCAR2—GPCR downstream signaling—TSHR—thyroid cancer	0.0013	0.00373	CbGpPWpGaD
Niacin—Cough—Sorafenib—thyroid cancer	0.00129	0.00251	CcSEcCtD
Niacin—Asthenia—Vandetanib—thyroid cancer	0.00129	0.0025	CcSEcCtD
Niacin—Bone disorder—Doxorubicin—thyroid cancer	0.00128	0.00249	CcSEcCtD
Niacin—Skin discolouration—Doxorubicin—thyroid cancer	0.00128	0.00249	CcSEcCtD
Niacin—Blood uric acid increased—Epirubicin—thyroid cancer	0.00128	0.00248	CcSEcCtD
Niacin—Hyperbilirubinaemia—Doxorubicin—thyroid cancer	0.00128	0.00248	CcSEcCtD
Niacin—Pruritus—Vandetanib—thyroid cancer	0.00127	0.00246	CcSEcCtD
Niacin—Cough increased—Doxorubicin—thyroid cancer	0.00127	0.00246	CcSEcCtD
Niacin—Arthralgia—Sorafenib—thyroid cancer	0.00126	0.00245	CcSEcCtD
Niacin—Myalgia—Sorafenib—thyroid cancer	0.00126	0.00245	CcSEcCtD
Niacin—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—thyroid cancer	0.00125	0.00243	CcSEcCtD
Niacin—Vaginal inflammation—Epirubicin—thyroid cancer	0.00125	0.00243	CcSEcCtD
Niacin—Hyperuricaemia—Doxorubicin—thyroid cancer	0.00125	0.00243	CcSEcCtD
Niacin—Dermatitis contact—Epirubicin—thyroid cancer	0.00124	0.00241	CcSEcCtD
Niacin—Dry mouth—Sorafenib—thyroid cancer	0.00124	0.0024	CcSEcCtD
Niacin—Eructation—Epirubicin—thyroid cancer	0.00123	0.00239	CcSEcCtD
Niacin—HCAR3—GPCR downstream signaling—TSHR—thyroid cancer	0.00123	0.00354	CbGpPWpGaD
Niacin—Diarrhoea—Vandetanib—thyroid cancer	0.00123	0.00238	CcSEcCtD
Niacin—Anaphylactic shock—Sorafenib—thyroid cancer	0.00121	0.00235	CcSEcCtD
Niacin—Skin exfoliation—Epirubicin—thyroid cancer	0.0012	0.00232	CcSEcCtD
Niacin—Shock—Sorafenib—thyroid cancer	0.00119	0.00231	CcSEcCtD
Niacin—Fluid retention—Epirubicin—thyroid cancer	0.00119	0.00231	CcSEcCtD
Niacin—SLC5A8—Transmembrane transport of small molecules—RXRA—thyroid cancer	0.00119	0.00342	CbGpPWpGaD
Niacin—Dizziness—Vandetanib—thyroid cancer	0.00119	0.0023	CcSEcCtD
Niacin—Vaginal infection—Epirubicin—thyroid cancer	0.00118	0.0023	CcSEcCtD
Niacin—Blood uric acid increased—Doxorubicin—thyroid cancer	0.00118	0.00229	CcSEcCtD
Niacin—HCAR2—Signaling by GPCR—TSHR—thyroid cancer	0.00118	0.00339	CbGpPWpGaD
Niacin—Skin disorder—Sorafenib—thyroid cancer	0.00118	0.00228	CcSEcCtD
Niacin—SLC16A3—Metabolism—MINPP1—thyroid cancer	0.00117	0.00336	CbGpPWpGaD
Niacin—Vaginal inflammation—Doxorubicin—thyroid cancer	0.00116	0.00225	CcSEcCtD
Niacin—HCAR2—Signaling by GPCR—PRKAR1A—thyroid cancer	0.00116	0.00333	CbGpPWpGaD
Niacin—Anorexia—Sorafenib—thyroid cancer	0.00115	0.00224	CcSEcCtD
Niacin—Cramps of lower extremities—Epirubicin—thyroid cancer	0.00115	0.00224	CcSEcCtD
Niacin—Dermatitis contact—Doxorubicin—thyroid cancer	0.00115	0.00223	CcSEcCtD
Niacin—Oesophagitis—Epirubicin—thyroid cancer	0.00115	0.00222	CcSEcCtD
Niacin—Vomiting—Vandetanib—thyroid cancer	0.00114	0.00221	CcSEcCtD
Niacin—Eructation—Doxorubicin—thyroid cancer	0.00114	0.00221	CcSEcCtD
Niacin—Rash maculo-papular—Epirubicin—thyroid cancer	0.00114	0.00221	CcSEcCtD
Niacin—QPRT—Disease—TPR—thyroid cancer	0.00114	0.00327	CbGpPWpGaD
Niacin—Rash—Vandetanib—thyroid cancer	0.00113	0.0022	CcSEcCtD
Niacin—Dermatitis—Vandetanib—thyroid cancer	0.00113	0.00219	CcSEcCtD
Niacin—Headache—Vandetanib—thyroid cancer	0.00112	0.00218	CcSEcCtD
Niacin—QPRT—Disease—PRKAR1A—thyroid cancer	0.00112	0.00322	CbGpPWpGaD
Niacin—HCAR3—Signaling by GPCR—TSHR—thyroid cancer	0.00112	0.00321	CbGpPWpGaD
Niacin—Skin exfoliation—Doxorubicin—thyroid cancer	0.00111	0.00215	CcSEcCtD
Niacin—Musculoskeletal discomfort—Sorafenib—thyroid cancer	0.0011	0.00214	CcSEcCtD
Niacin—SLCO2B1—SLC-mediated transmembrane transport—CP—thyroid cancer	0.0011	0.00317	CbGpPWpGaD
Niacin—SLCO2B1—SLC-mediated transmembrane transport—TPR—thyroid cancer	0.0011	0.00317	CbGpPWpGaD
Niacin—Fluid retention—Doxorubicin—thyroid cancer	0.0011	0.00214	CcSEcCtD
Niacin—Hypertonia—Epirubicin—thyroid cancer	0.0011	0.00213	CcSEcCtD
Niacin—HCAR3—Signaling by GPCR—PRKAR1A—thyroid cancer	0.0011	0.00316	CbGpPWpGaD
Niacin—Vaginal infection—Doxorubicin—thyroid cancer	0.0011	0.00213	CcSEcCtD
Niacin—Abnormal vision—Epirubicin—thyroid cancer	0.00109	0.00212	CcSEcCtD
Niacin—Dyspnoea—Sorafenib—thyroid cancer	0.00108	0.00209	CcSEcCtD
Niacin—QPRT—Disease—MEN1—thyroid cancer	0.00107	0.00307	CbGpPWpGaD
Niacin—Nausea—Vandetanib—thyroid cancer	0.00107	0.00207	CcSEcCtD
Niacin—Cramps of lower extremities—Doxorubicin—thyroid cancer	0.00107	0.00207	CcSEcCtD
Niacin—Dyspepsia—Sorafenib—thyroid cancer	0.00107	0.00207	CcSEcCtD
Niacin—Oesophagitis—Doxorubicin—thyroid cancer	0.00106	0.00206	CcSEcCtD
Niacin—Rash maculo-papular—Doxorubicin—thyroid cancer	0.00105	0.00205	CcSEcCtD
Niacin—Decreased appetite—Sorafenib—thyroid cancer	0.00105	0.00204	CcSEcCtD
Niacin—SLC16A3—Hemostasis—PRKAR1A—thyroid cancer	0.00105	0.00302	CbGpPWpGaD
Niacin—Diabetes mellitus—Epirubicin—thyroid cancer	0.00105	0.00203	CcSEcCtD
Niacin—Gastrointestinal disorder—Sorafenib—thyroid cancer	0.00105	0.00203	CcSEcCtD
Niacin—Hepatic function abnormal—Epirubicin—thyroid cancer	0.00104	0.00202	CcSEcCtD
Niacin—Pain—Sorafenib—thyroid cancer	0.00104	0.00201	CcSEcCtD
Niacin—Hypertonia—Doxorubicin—thyroid cancer	0.00102	0.00197	CcSEcCtD
Niacin—Eczema—Epirubicin—thyroid cancer	0.00101	0.00197	CcSEcCtD
Niacin—Abnormal vision—Doxorubicin—thyroid cancer	0.00101	0.00196	CcSEcCtD
Niacin—HCAR2—GPCR downstream signaling—SST—thyroid cancer	0.00101	0.0029	CbGpPWpGaD
Niacin—HCAR2—Signaling by GPCR—PTCH1—thyroid cancer	0.001	0.00288	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—NDUFA13—thyroid cancer	0.000992	0.00286	CbGpPWpGaD
Niacin—Gastrointestinal pain—Sorafenib—thyroid cancer	0.00099	0.00192	CcSEcCtD
Niacin—SLC16A1—SLC-mediated transmembrane transport—TPR—thyroid cancer	0.00098	0.00282	CbGpPWpGaD
Niacin—SLC16A1—SLC-mediated transmembrane transport—CP—thyroid cancer	0.00098	0.00282	CbGpPWpGaD
Niacin—SLC16A1—The citric acid (TCA) cycle and respiratory electron transport—RXRA—thyroid cancer	0.000972	0.0028	CbGpPWpGaD
Niacin—HCAR2—GPCR downstream signaling—CALCA—thyroid cancer	0.00097	0.00279	CbGpPWpGaD
Niacin—Diabetes mellitus—Doxorubicin—thyroid cancer	0.000968	0.00188	CcSEcCtD
Niacin—Hepatic function abnormal—Doxorubicin—thyroid cancer	0.000964	0.00187	CcSEcCtD
Niacin—Urticaria—Sorafenib—thyroid cancer	0.000962	0.00187	CcSEcCtD
Niacin—Abdominal pain—Sorafenib—thyroid cancer	0.000957	0.00186	CcSEcCtD
Niacin—Body temperature increased—Sorafenib—thyroid cancer	0.000957	0.00186	CcSEcCtD
Niacin—HCAR3—GPCR downstream signaling—SST—thyroid cancer	0.000955	0.00275	CbGpPWpGaD
Niacin—SLC16A3—Cell surface interactions at the vascular wall—NRAS—thyroid cancer	0.000955	0.00275	CbGpPWpGaD
Niacin—Dermatitis bullous—Epirubicin—thyroid cancer	0.000953	0.00185	CcSEcCtD
Niacin—QPRT—Metabolism—TPR—thyroid cancer	0.000951	0.00274	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—TCF7L1—thyroid cancer	0.00095	0.00273	CbGpPWpGaD
Niacin—HCAR3—Signaling by GPCR—PTCH1—thyroid cancer	0.000948	0.00273	CbGpPWpGaD
Niacin—Eczema—Doxorubicin—thyroid cancer	0.000937	0.00182	CcSEcCtD
Niacin—QPRT—Metabolism—PRKAR1A—thyroid cancer	0.000936	0.00269	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—CHST14—thyroid cancer	0.000933	0.00269	CbGpPWpGaD
Niacin—SLC16A3—Transmembrane transport of small molecules—TPR—thyroid cancer	0.000922	0.00265	CbGpPWpGaD
Niacin—SLC16A3—Transmembrane transport of small molecules—CP—thyroid cancer	0.000922	0.00265	CbGpPWpGaD
Niacin—HCAR3—GPCR downstream signaling—CALCA—thyroid cancer	0.000919	0.00265	CbGpPWpGaD
Niacin—HCAR2—Signaling by GPCR—SST—thyroid cancer	0.000915	0.00263	CbGpPWpGaD
Niacin—Gastrointestinal haemorrhage—Epirubicin—thyroid cancer	0.00091	0.00177	CcSEcCtD
Niacin—SLC16A3—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	0.000907	0.00261	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—TCF7L1—thyroid cancer	0.0009	0.00259	CbGpPWpGaD
Niacin—Migraine—Epirubicin—thyroid cancer	0.000896	0.00174	CcSEcCtD
Niacin—Hypersensitivity—Sorafenib—thyroid cancer	0.000892	0.00173	CcSEcCtD
Niacin—NNMT—Metabolism—TPR—thyroid cancer	0.000884	0.00255	CbGpPWpGaD
Niacin—Dermatitis bullous—Doxorubicin—thyroid cancer	0.000881	0.00171	CcSEcCtD
Niacin—HCAR2—Signaling by GPCR—CALCA—thyroid cancer	0.000881	0.00254	CbGpPWpGaD
Niacin—Face oedema—Epirubicin—thyroid cancer	0.000879	0.00171	CcSEcCtD
Niacin—NNMT—Metabolism—PRKAR1A—thyroid cancer	0.00087	0.0025	CbGpPWpGaD
Niacin—Asthenia—Sorafenib—thyroid cancer	0.000869	0.00169	CcSEcCtD
Niacin—HCAR3—Signaling by GPCR—SST—thyroid cancer	0.000867	0.0025	CbGpPWpGaD
Niacin—Pruritus—Sorafenib—thyroid cancer	0.000857	0.00166	CcSEcCtD
Niacin—QPRT—Disease—CALCA—thyroid cancer	0.00085	0.00245	CbGpPWpGaD
Niacin—SLC22A5—SLC-mediated transmembrane transport—CP—thyroid cancer	0.000842	0.00243	CbGpPWpGaD
Niacin—SLC22A5—SLC-mediated transmembrane transport—TPR—thyroid cancer	0.000842	0.00243	CbGpPWpGaD
Niacin—Gastrointestinal haemorrhage—Doxorubicin—thyroid cancer	0.000842	0.00163	CcSEcCtD
Niacin—Liver function test abnormal—Epirubicin—thyroid cancer	0.00084	0.00163	CcSEcCtD
Niacin—HCAR3—Signaling by GPCR—CALCA—thyroid cancer	0.000835	0.0024	CbGpPWpGaD
Niacin—Dry skin—Epirubicin—thyroid cancer	0.000834	0.00162	CcSEcCtD
Niacin—Orthostatic hypotension—Epirubicin—thyroid cancer	0.000831	0.00161	CcSEcCtD
Niacin—Migraine—Doxorubicin—thyroid cancer	0.000829	0.00161	CcSEcCtD
Niacin—Diarrhoea—Sorafenib—thyroid cancer	0.000828	0.00161	CcSEcCtD
Niacin—SLCO2B1—SLC-mediated transmembrane transport—SLC5A5—thyroid cancer	0.000825	0.00238	CbGpPWpGaD
Niacin—SLC16A3—Cell surface interactions at the vascular wall—KRAS—thyroid cancer	0.000822	0.00237	CbGpPWpGaD
Niacin—Face oedema—Doxorubicin—thyroid cancer	0.000813	0.00158	CcSEcCtD
Niacin—CYP2D6—Metapathway biotransformation—CHST14—thyroid cancer	0.000809	0.00233	CbGpPWpGaD
Niacin—Muscular weakness—Epirubicin—thyroid cancer	0.000803	0.00156	CcSEcCtD
Niacin—Dizziness—Sorafenib—thyroid cancer	0.000801	0.00155	CcSEcCtD
Niacin—HCAR2—Signaling by GPCR—CDK1—thyroid cancer	0.000797	0.0023	CbGpPWpGaD
Niacin—Abdominal distension—Epirubicin—thyroid cancer	0.000792	0.00154	CcSEcCtD
Niacin—Dysphagia—Epirubicin—thyroid cancer	0.000787	0.00153	CcSEcCtD
Niacin—Influenza—Epirubicin—thyroid cancer	0.000787	0.00153	CcSEcCtD
Niacin—Liver function test abnormal—Doxorubicin—thyroid cancer	0.000778	0.00151	CcSEcCtD
Niacin—Dry skin—Doxorubicin—thyroid cancer	0.000772	0.0015	CcSEcCtD
Niacin—Vomiting—Sorafenib—thyroid cancer	0.00077	0.00149	CcSEcCtD
Niacin—QPRT—Disease—CDK1—thyroid cancer	0.000769	0.00222	CbGpPWpGaD
Niacin—Orthostatic hypotension—Doxorubicin—thyroid cancer	0.000769	0.00149	CcSEcCtD
Niacin—Angina pectoris—Epirubicin—thyroid cancer	0.000766	0.00149	CcSEcCtD
Niacin—Rash—Sorafenib—thyroid cancer	0.000763	0.00148	CcSEcCtD
Niacin—Dermatitis—Sorafenib—thyroid cancer	0.000763	0.00148	CcSEcCtD
Niacin—Headache—Sorafenib—thyroid cancer	0.000758	0.00147	CcSEcCtD
Niacin—Bronchitis—Epirubicin—thyroid cancer	0.000757	0.00147	CcSEcCtD
Niacin—HCAR3—Signaling by GPCR—CDK1—thyroid cancer	0.000756	0.00218	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—HPGD—thyroid cancer	0.000752	0.00216	CbGpPWpGaD
Niacin—Muscular weakness—Doxorubicin—thyroid cancer	0.000743	0.00144	CcSEcCtD
Niacin—SLC16A1—SLC-mediated transmembrane transport—SLC5A5—thyroid cancer	0.000733	0.00211	CbGpPWpGaD
Niacin—Abdominal distension—Doxorubicin—thyroid cancer	0.000733	0.00142	CcSEcCtD
Niacin—Dysphagia—Doxorubicin—thyroid cancer	0.000728	0.00141	CcSEcCtD
Niacin—Influenza—Doxorubicin—thyroid cancer	0.000728	0.00141	CcSEcCtD
Niacin—Nausea—Sorafenib—thyroid cancer	0.000719	0.0014	CcSEcCtD
Niacin—QPRT—Metabolism—SLC5A5—thyroid cancer	0.000712	0.00205	CbGpPWpGaD
Niacin—Angina pectoris—Doxorubicin—thyroid cancer	0.000709	0.00138	CcSEcCtD
Niacin—Bronchitis—Doxorubicin—thyroid cancer	0.0007	0.00136	CcSEcCtD
Niacin—SLC16A3—Cell surface interactions at the vascular wall—HRAS—thyroid cancer	0.000698	0.00201	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—TSHR—thyroid cancer	0.000695	0.002	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—IFNA2—thyroid cancer	0.000694	0.002	CbGpPWpGaD
Niacin—SLC16A3—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	0.00069	0.00199	CbGpPWpGaD
Niacin—Jaundice—Epirubicin—thyroid cancer	0.000684	0.00133	CcSEcCtD
Niacin—Stomatitis—Epirubicin—thyroid cancer	0.000684	0.00133	CcSEcCtD
Niacin—HCAR2—Signaling Pathways—PRKAR1A—thyroid cancer	0.000684	0.00197	CbGpPWpGaD
Niacin—Sweating—Epirubicin—thyroid cancer	0.000673	0.00131	CcSEcCtD
Niacin—NNMT—Metabolism—SLC5A5—thyroid cancer	0.000662	0.00191	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—TSHR—thyroid cancer	0.000659	0.0019	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—MEN1—thyroid cancer	0.000653	0.00188	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—PRKAR1A—thyroid cancer	0.000648	0.00187	CbGpPWpGaD
Niacin—Haemoglobin—Epirubicin—thyroid cancer	0.000633	0.00123	CcSEcCtD
Niacin—Stomatitis—Doxorubicin—thyroid cancer	0.000633	0.00123	CcSEcCtD
Niacin—Jaundice—Doxorubicin—thyroid cancer	0.000633	0.00123	CcSEcCtD
Niacin—Rhinitis—Epirubicin—thyroid cancer	0.000631	0.00123	CcSEcCtD
Niacin—SLC22A5—SLC-mediated transmembrane transport—SLC5A5—thyroid cancer	0.000631	0.00182	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—MINPP1—thyroid cancer	0.00063	0.00181	CbGpPWpGaD
Niacin—Hepatitis—Epirubicin—thyroid cancer	0.00063	0.00122	CcSEcCtD
Niacin—Haemorrhage—Epirubicin—thyroid cancer	0.00063	0.00122	CcSEcCtD
Niacin—Hypoaesthesia—Epirubicin—thyroid cancer	0.000627	0.00122	CcSEcCtD
Niacin—Sweating—Doxorubicin—thyroid cancer	0.000622	0.00121	CcSEcCtD
Niacin—Oedema peripheral—Epirubicin—thyroid cancer	0.00062	0.0012	CcSEcCtD
Niacin—HCAR3—Signaling Pathways—MEN1—thyroid cancer	0.000619	0.00178	CbGpPWpGaD
Niacin—QPRT—Disease—NRG1—thyroid cancer	0.000618	0.00178	CbGpPWpGaD
Niacin—Visual impairment—Epirubicin—thyroid cancer	0.000607	0.00118	CcSEcCtD
Niacin—QPRT—Metabolism—RXRA—thyroid cancer	0.000598	0.00172	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—PTCH1—thyroid cancer	0.000591	0.0017	CbGpPWpGaD
Niacin—Eye disorder—Epirubicin—thyroid cancer	0.000589	0.00114	CcSEcCtD
Niacin—Tinnitus—Epirubicin—thyroid cancer	0.000587	0.00114	CcSEcCtD
Niacin—Haemoglobin—Doxorubicin—thyroid cancer	0.000586	0.00114	CcSEcCtD
Niacin—Flushing—Epirubicin—thyroid cancer	0.000584	0.00113	CcSEcCtD
Niacin—Rhinitis—Doxorubicin—thyroid cancer	0.000584	0.00113	CcSEcCtD
Niacin—Haemorrhage—Doxorubicin—thyroid cancer	0.000583	0.00113	CcSEcCtD
Niacin—Hepatitis—Doxorubicin—thyroid cancer	0.000583	0.00113	CcSEcCtD
Niacin—Hypoaesthesia—Doxorubicin—thyroid cancer	0.00058	0.00113	CcSEcCtD
Niacin—SLC16A3—Transmembrane transport of small molecules—RXRA—thyroid cancer	0.00058	0.00167	CbGpPWpGaD
Niacin—Oedema peripheral—Doxorubicin—thyroid cancer	0.000574	0.00111	CcSEcCtD
Niacin—Angiopathy—Epirubicin—thyroid cancer	0.000571	0.00111	CcSEcCtD
Niacin—SLC16A1—Hemostasis—PRKAR1A—thyroid cancer	0.000566	0.00163	CbGpPWpGaD
Niacin—Chills—Epirubicin—thyroid cancer	0.000565	0.0011	CcSEcCtD
Niacin—Arrhythmia—Epirubicin—thyroid cancer	0.000563	0.00109	CcSEcCtD
Niacin—Visual impairment—Doxorubicin—thyroid cancer	0.000562	0.00109	CcSEcCtD
Niacin—SLCO2B1—Transmembrane transport of small molecules—CP—thyroid cancer	0.00056	0.00161	CbGpPWpGaD
Niacin—SLCO2B1—Transmembrane transport of small molecules—TPR—thyroid cancer	0.00056	0.00161	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—PTCH1—thyroid cancer	0.00056	0.00161	CbGpPWpGaD
Niacin—Alopecia—Epirubicin—thyroid cancer	0.000557	0.00108	CcSEcCtD
Niacin—NNMT—Metabolism—RXRA—thyroid cancer	0.000556	0.0016	CbGpPWpGaD
Niacin—CYP2D6—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	0.000555	0.0016	CbGpPWpGaD
Niacin—QPRT—Disease—TERT—thyroid cancer	0.000555	0.0016	CbGpPWpGaD
Niacin—SLCO2B1—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	0.000551	0.00159	CbGpPWpGaD
Niacin—Erythema—Epirubicin—thyroid cancer	0.000548	0.00106	CcSEcCtD
Niacin—Malnutrition—Epirubicin—thyroid cancer	0.000548	0.00106	CcSEcCtD
Niacin—Eye disorder—Doxorubicin—thyroid cancer	0.000545	0.00106	CcSEcCtD
Niacin—Tinnitus—Doxorubicin—thyroid cancer	0.000543	0.00105	CcSEcCtD
Niacin—Flushing—Doxorubicin—thyroid cancer	0.000541	0.00105	CcSEcCtD
Niacin—HCAR2—Signaling Pathways—SST—thyroid cancer	0.000541	0.00156	CbGpPWpGaD
Niacin—Flatulence—Epirubicin—thyroid cancer	0.00054	0.00105	CcSEcCtD
Niacin—Tension—Epirubicin—thyroid cancer	0.000538	0.00104	CcSEcCtD
Niacin—SLC16A1—Metabolism—NDUFA13—thyroid cancer	0.000536	0.00154	CbGpPWpGaD
Niacin—Nervousness—Epirubicin—thyroid cancer	0.000532	0.00103	CcSEcCtD
Niacin—QPRT—Disease—HIF1A—thyroid cancer	0.00053	0.00153	CbGpPWpGaD
Niacin—Angiopathy—Doxorubicin—thyroid cancer	0.000529	0.00103	CcSEcCtD
Niacin—Muscle spasms—Epirubicin—thyroid cancer	0.000527	0.00102	CcSEcCtD
Niacin—Chills—Doxorubicin—thyroid cancer	0.000523	0.00101	CcSEcCtD
Niacin—Arrhythmia—Doxorubicin—thyroid cancer	0.000521	0.00101	CcSEcCtD
Niacin—HCAR2—Signaling Pathways—CALCA—thyroid cancer	0.00052	0.0015	CbGpPWpGaD
Niacin—Vision blurred—Epirubicin—thyroid cancer	0.000517	0.001	CcSEcCtD
Niacin—SLC16A1—Cell surface interactions at the vascular wall—NRAS—thyroid cancer	0.000515	0.00148	CbGpPWpGaD
Niacin—Alopecia—Doxorubicin—thyroid cancer	0.000515	0.000999	CcSEcCtD
Niacin—HCAR3—Signaling Pathways—SST—thyroid cancer	0.000512	0.00148	CbGpPWpGaD
Niacin—Erythema—Doxorubicin—thyroid cancer	0.000507	0.000984	CcSEcCtD
Niacin—Malnutrition—Doxorubicin—thyroid cancer	0.000507	0.000984	CcSEcCtD
Niacin—SLC16A1—Metabolism—CHST14—thyroid cancer	0.000504	0.00145	CbGpPWpGaD
Niacin—Flatulence—Doxorubicin—thyroid cancer	0.0005	0.00097	CcSEcCtD
Niacin—SLC16A1—Transmembrane transport of small molecules—TPR—thyroid cancer	0.000498	0.00143	CbGpPWpGaD
Niacin—SLC16A1—Transmembrane transport of small molecules—CP—thyroid cancer	0.000498	0.00143	CbGpPWpGaD
Niacin—Tension—Doxorubicin—thyroid cancer	0.000498	0.000966	CcSEcCtD
Niacin—HCAR3—Signaling Pathways—CALCA—thyroid cancer	0.000493	0.00142	CbGpPWpGaD
Niacin—Nervousness—Doxorubicin—thyroid cancer	0.000493	0.000956	CcSEcCtD
Niacin—Vertigo—Epirubicin—thyroid cancer	0.000493	0.000956	CcSEcCtD
Niacin—Syncope—Epirubicin—thyroid cancer	0.000492	0.000954	CcSEcCtD
Niacin—Leukopenia—Epirubicin—thyroid cancer	0.000491	0.000952	CcSEcCtD
Niacin—SLC16A1—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	0.00049	0.00141	CbGpPWpGaD
Niacin—Muscle spasms—Doxorubicin—thyroid cancer	0.000488	0.000946	CcSEcCtD
Niacin—Palpitations—Epirubicin—thyroid cancer	0.000484	0.00094	CcSEcCtD
Niacin—Loss of consciousness—Epirubicin—thyroid cancer	0.000482	0.000935	CcSEcCtD
Niacin—Cough—Epirubicin—thyroid cancer	0.000478	0.000928	CcSEcCtD
Niacin—Vision blurred—Doxorubicin—thyroid cancer	0.000478	0.000928	CcSEcCtD
Niacin—HCAR2—Signaling Pathways—CDK1—thyroid cancer	0.000471	0.00136	CbGpPWpGaD
Niacin—Arthralgia—Epirubicin—thyroid cancer	0.000467	0.000906	CcSEcCtD
Niacin—Myalgia—Epirubicin—thyroid cancer	0.000467	0.000906	CcSEcCtD
Niacin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—thyroid cancer	0.000464	0.0009	CcSEcCtD
Niacin—Dry mouth—Epirubicin—thyroid cancer	0.000456	0.000886	CcSEcCtD
Niacin—Vertigo—Doxorubicin—thyroid cancer	0.000456	0.000884	CcSEcCtD
Niacin—Syncope—Doxorubicin—thyroid cancer	0.000455	0.000883	CcSEcCtD
Niacin—Leukopenia—Doxorubicin—thyroid cancer	0.000454	0.000881	CcSEcCtD
Niacin—CYP2D6—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	0.00045	0.00129	CbGpPWpGaD
Niacin—Palpitations—Doxorubicin—thyroid cancer	0.000448	0.00087	CcSEcCtD
Niacin—Oedema—Epirubicin—thyroid cancer	0.000447	0.000868	CcSEcCtD
Niacin—Anaphylactic shock—Epirubicin—thyroid cancer	0.000447	0.000868	CcSEcCtD
Niacin—HCAR3—Signaling Pathways—CDK1—thyroid cancer	0.000446	0.00129	CbGpPWpGaD
Niacin—Loss of consciousness—Doxorubicin—thyroid cancer	0.000446	0.000865	CcSEcCtD
Niacin—SLC16A1—Cell surface interactions at the vascular wall—KRAS—thyroid cancer	0.000444	0.00128	CbGpPWpGaD
Niacin—Cough—Doxorubicin—thyroid cancer	0.000443	0.000859	CcSEcCtD
Niacin—Shock—Epirubicin—thyroid cancer	0.00044	0.000854	CcSEcCtD
Niacin—QPRT—Disease—BRAF—thyroid cancer	0.000439	0.00126	CbGpPWpGaD
Niacin—Tachycardia—Epirubicin—thyroid cancer	0.000437	0.000847	CcSEcCtD
Niacin—Skin disorder—Epirubicin—thyroid cancer	0.000435	0.000843	CcSEcCtD
Niacin—Hyperhidrosis—Epirubicin—thyroid cancer	0.000433	0.000839	CcSEcCtD
Niacin—Arthralgia—Doxorubicin—thyroid cancer	0.000432	0.000838	CcSEcCtD
Niacin—Myalgia—Doxorubicin—thyroid cancer	0.000432	0.000838	CcSEcCtD
Niacin—SLC16A3—Metabolism—TPR—thyroid cancer	0.000432	0.00124	CbGpPWpGaD
Niacin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—thyroid cancer	0.000429	0.000832	CcSEcCtD
Niacin—SLC22A5—Transmembrane transport of small molecules—TPR—thyroid cancer	0.000428	0.00123	CbGpPWpGaD
Niacin—SLC22A5—Transmembrane transport of small molecules—CP—thyroid cancer	0.000428	0.00123	CbGpPWpGaD
Niacin—Anorexia—Epirubicin—thyroid cancer	0.000426	0.000828	CcSEcCtD
Niacin—SLC16A3—Metabolism—PRKAR1A—thyroid cancer	0.000425	0.00122	CbGpPWpGaD
Niacin—Dry mouth—Doxorubicin—thyroid cancer	0.000422	0.00082	CcSEcCtD
Niacin—SLC22A5—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	0.000421	0.00121	CbGpPWpGaD
Niacin—SLCO2B1—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	0.000419	0.00121	CbGpPWpGaD
Niacin—Hypotension—Epirubicin—thyroid cancer	0.000418	0.000811	CcSEcCtD
Niacin—Anaphylactic shock—Doxorubicin—thyroid cancer	0.000414	0.000803	CcSEcCtD
Niacin—Oedema—Doxorubicin—thyroid cancer	0.000414	0.000803	CcSEcCtD
Niacin—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.000408	0.000791	CcSEcCtD
Niacin—Shock—Doxorubicin—thyroid cancer	0.000407	0.00079	CcSEcCtD
Niacin—SLC16A1—Metabolism—HPGD—thyroid cancer	0.000406	0.00117	CbGpPWpGaD
Niacin—Insomnia—Epirubicin—thyroid cancer	0.000405	0.000785	CcSEcCtD
Niacin—Tachycardia—Doxorubicin—thyroid cancer	0.000404	0.000784	CcSEcCtD
Niacin—Skin disorder—Doxorubicin—thyroid cancer	0.000402	0.00078	CcSEcCtD
Niacin—Paraesthesia—Epirubicin—thyroid cancer	0.000402	0.00078	CcSEcCtD
Niacin—Hyperhidrosis—Doxorubicin—thyroid cancer	0.0004	0.000777	CcSEcCtD
Niacin—Dyspnoea—Epirubicin—thyroid cancer	0.000399	0.000774	CcSEcCtD
Niacin—Somnolence—Epirubicin—thyroid cancer	0.000398	0.000772	CcSEcCtD
Niacin—Anorexia—Doxorubicin—thyroid cancer	0.000395	0.000766	CcSEcCtD
Niacin—Dyspepsia—Epirubicin—thyroid cancer	0.000394	0.000764	CcSEcCtD
Niacin—Decreased appetite—Epirubicin—thyroid cancer	0.000389	0.000755	CcSEcCtD
Niacin—Hypotension—Doxorubicin—thyroid cancer	0.000387	0.000751	CcSEcCtD
Niacin—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.000386	0.00075	CcSEcCtD
Niacin—Pain—Epirubicin—thyroid cancer	0.000383	0.000743	CcSEcCtD
Niacin—HCAR2—Signaling Pathways—NRG1—thyroid cancer	0.000378	0.00109	CbGpPWpGaD
Niacin—QPRT—Metabolism—PPARG—thyroid cancer	0.000378	0.00109	CbGpPWpGaD
Niacin—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	0.000377	0.000732	CcSEcCtD
Niacin—SLC16A1—Cell surface interactions at the vascular wall—HRAS—thyroid cancer	0.000377	0.00109	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—IFNA2—thyroid cancer	0.000375	0.00108	CbGpPWpGaD
Niacin—Insomnia—Doxorubicin—thyroid cancer	0.000374	0.000727	CcSEcCtD
Niacin—SLC16A1—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	0.000373	0.00107	CbGpPWpGaD
Niacin—Paraesthesia—Doxorubicin—thyroid cancer	0.000372	0.000721	CcSEcCtD
Niacin—Dyspnoea—Doxorubicin—thyroid cancer	0.000369	0.000716	CcSEcCtD
Niacin—Somnolence—Doxorubicin—thyroid cancer	0.000368	0.000714	CcSEcCtD
Niacin—Gastrointestinal pain—Epirubicin—thyroid cancer	0.000366	0.00071	CcSEcCtD
Niacin—Dyspepsia—Doxorubicin—thyroid cancer	0.000364	0.000707	CcSEcCtD
Niacin—Decreased appetite—Doxorubicin—thyroid cancer	0.00036	0.000698	CcSEcCtD
Niacin—HCAR3—Signaling Pathways—NRG1—thyroid cancer	0.000358	0.00103	CbGpPWpGaD
Niacin—Gastrointestinal disorder—Doxorubicin—thyroid cancer	0.000357	0.000694	CcSEcCtD
Niacin—Urticaria—Epirubicin—thyroid cancer	0.000355	0.00069	CcSEcCtD
Niacin—QPRT—Disease—PTGS2—thyroid cancer	0.000355	0.00102	CbGpPWpGaD
Niacin—Pain—Doxorubicin—thyroid cancer	0.000354	0.000687	CcSEcCtD
Niacin—Body temperature increased—Epirubicin—thyroid cancer	0.000354	0.000686	CcSEcCtD
Niacin—Abdominal pain—Epirubicin—thyroid cancer	0.000354	0.000686	CcSEcCtD
Niacin—SLCO2B1—Transmembrane transport of small molecules—RXRA—thyroid cancer	0.000352	0.00101	CbGpPWpGaD
Niacin—NNMT—Metabolism—PPARG—thyroid cancer	0.000351	0.00101	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—TERT—thyroid cancer	0.000339	0.000977	CbGpPWpGaD
Niacin—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.000339	0.000657	CcSEcCtD
Niacin—Hypersensitivity—Epirubicin—thyroid cancer	0.00033	0.00064	CcSEcCtD
Niacin—Urticaria—Doxorubicin—thyroid cancer	0.000329	0.000638	CcSEcCtD
Niacin—Abdominal pain—Doxorubicin—thyroid cancer	0.000327	0.000635	CcSEcCtD
Niacin—Body temperature increased—Doxorubicin—thyroid cancer	0.000327	0.000635	CcSEcCtD
Niacin—HCAR2—Signaling Pathways—HIF1A—thyroid cancer	0.000325	0.000935	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—SLC5A5—thyroid cancer	0.000323	0.000931	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—TERT—thyroid cancer	0.000322	0.000926	CbGpPWpGaD
Niacin—Asthenia—Epirubicin—thyroid cancer	0.000321	0.000623	CcSEcCtD
Niacin—SLC22A5—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	0.00032	0.000923	CbGpPWpGaD
Niacin—Pruritus—Epirubicin—thyroid cancer	0.000317	0.000614	CcSEcCtD
Niacin—SLC16A1—Transmembrane transport of small molecules—RXRA—thyroid cancer	0.000313	0.000901	CbGpPWpGaD
Niacin—QPRT—Disease—PTEN—thyroid cancer	0.000309	0.000891	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—HIF1A—thyroid cancer	0.000308	0.000886	CbGpPWpGaD
Niacin—Diarrhoea—Epirubicin—thyroid cancer	0.000306	0.000594	CcSEcCtD
Niacin—Hypersensitivity—Doxorubicin—thyroid cancer	0.000305	0.000592	CcSEcCtD
Niacin—QPRT—Metabolism—PTGS2—thyroid cancer	0.000297	0.000855	CbGpPWpGaD
Niacin—Asthenia—Doxorubicin—thyroid cancer	0.000297	0.000576	CcSEcCtD
Niacin—Dizziness—Epirubicin—thyroid cancer	0.000296	0.000574	CcSEcCtD
Niacin—Pruritus—Doxorubicin—thyroid cancer	0.000293	0.000568	CcSEcCtD
Niacin—HCAR2—Signaling by GPCR—NRAS—thyroid cancer	0.000286	0.000823	CbGpPWpGaD
Niacin—Vomiting—Epirubicin—thyroid cancer	0.000284	0.000552	CcSEcCtD
Niacin—Diarrhoea—Doxorubicin—thyroid cancer	0.000283	0.00055	CcSEcCtD
Niacin—Rash—Epirubicin—thyroid cancer	0.000282	0.000547	CcSEcCtD
Niacin—Dermatitis—Epirubicin—thyroid cancer	0.000282	0.000547	CcSEcCtD
Niacin—Headache—Epirubicin—thyroid cancer	0.00028	0.000544	CcSEcCtD
Niacin—NNMT—Metabolism—PTGS2—thyroid cancer	0.000276	0.000795	CbGpPWpGaD
Niacin—QPRT—Disease—NRAS—thyroid cancer	0.000276	0.000795	CbGpPWpGaD
Niacin—Dizziness—Doxorubicin—thyroid cancer	0.000274	0.000531	CcSEcCtD
Niacin—SLC16A3—Metabolism—RXRA—thyroid cancer	0.000272	0.000782	CbGpPWpGaD
Niacin—HCAR3—Signaling by GPCR—NRAS—thyroid cancer	0.000271	0.000781	CbGpPWpGaD
Niacin—SLC22A5—Transmembrane transport of small molecules—RXRA—thyroid cancer	0.000269	0.000775	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—BRAF—thyroid cancer	0.000269	0.000774	CbGpPWpGaD
Niacin—Nausea—Epirubicin—thyroid cancer	0.000266	0.000516	CcSEcCtD
Niacin—Vomiting—Doxorubicin—thyroid cancer	0.000263	0.000511	CcSEcCtD
Niacin—Rash—Doxorubicin—thyroid cancer	0.000261	0.000507	CcSEcCtD
Niacin—Dermatitis—Doxorubicin—thyroid cancer	0.000261	0.000506	CcSEcCtD
Niacin—Headache—Doxorubicin—thyroid cancer	0.000259	0.000503	CcSEcCtD
Niacin—QPRT—Metabolism—PTEN—thyroid cancer	0.000259	0.000746	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—NRAS—thyroid cancer	0.000259	0.000745	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—BRAF—thyroid cancer	0.000255	0.000734	CbGpPWpGaD
Niacin—HCAR2—Signaling by GPCR—KRAS—thyroid cancer	0.000246	0.000709	CbGpPWpGaD
Niacin—Nausea—Doxorubicin—thyroid cancer	0.000246	0.000477	CcSEcCtD
Niacin—NNMT—Metabolism—PTEN—thyroid cancer	0.000241	0.000693	CbGpPWpGaD
Niacin—CYP2D6—Biological oxidations—RXRA—thyroid cancer	0.000239	0.000688	CbGpPWpGaD
Niacin—QPRT—Disease—KRAS—thyroid cancer	0.000238	0.000684	CbGpPWpGaD
Niacin—HCAR3—Signaling by GPCR—KRAS—thyroid cancer	0.000233	0.000672	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—TPR—thyroid cancer	0.000233	0.000671	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—PRKAR1A—thyroid cancer	0.000229	0.00066	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—KRAS—thyroid cancer	0.000223	0.000641	CbGpPWpGaD
Niacin—HCAR2—Signaling by GPCR—HRAS—thyroid cancer	0.000209	0.000602	CbGpPWpGaD
Niacin—HCAR2—GPCR downstream signaling—AKT1—thyroid cancer	0.000203	0.000586	CbGpPWpGaD
Niacin—QPRT—Disease—HRAS—thyroid cancer	0.000202	0.000581	CbGpPWpGaD
Niacin—HCAR3—Signaling by GPCR—HRAS—thyroid cancer	0.000198	0.000571	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—TP53—thyroid cancer	0.000198	0.00057	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—CCND1—thyroid cancer	0.000196	0.000565	CbGpPWpGaD
Niacin—HCAR3—GPCR downstream signaling—AKT1—thyroid cancer	0.000193	0.000555	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—HRAS—thyroid cancer	0.000189	0.000545	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—PTEN—thyroid cancer	0.000189	0.000545	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—CCND1—thyroid cancer	0.000186	0.000535	CbGpPWpGaD
Niacin—HCAR2—Signaling by GPCR—AKT1—thyroid cancer	0.000185	0.000532	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—PTEN—thyroid cancer	0.00018	0.000517	CbGpPWpGaD
Niacin—QPRT—Disease—AKT1—thyroid cancer	0.000178	0.000513	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—MINPP1—thyroid cancer	0.000175	0.000505	CbGpPWpGaD
Niacin—HCAR3—Signaling by GPCR—AKT1—thyroid cancer	0.000175	0.000504	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—SLC5A5—thyroid cancer	0.000175	0.000502	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—PPARG—thyroid cancer	0.000171	0.000494	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—NRAS—thyroid cancer	0.000169	0.000486	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—AKT1—thyroid cancer	0.000167	0.000481	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—NRAS—thyroid cancer	0.00016	0.000461	CbGpPWpGaD
Niacin—QPRT—Metabolism—AKT1—thyroid cancer	0.000149	0.00043	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—NDUFA13—thyroid cancer	0.000149	0.00043	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—RXRA—thyroid cancer	0.000147	0.000422	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—KRAS—thyroid cancer	0.000145	0.000419	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—CHST14—thyroid cancer	0.00014	0.000404	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—NRAS—thyroid cancer	0.00014	0.000402	CbGpPWpGaD
Niacin—NNMT—Metabolism—AKT1—thyroid cancer	0.000139	0.0004	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—KRAS—thyroid cancer	0.000138	0.000397	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—PTGS2—thyroid cancer	0.000135	0.000388	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—TP53—thyroid cancer	0.000129	0.000372	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—HRAS—thyroid cancer	0.000124	0.000356	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—TP53—thyroid cancer	0.000123	0.000353	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—KRAS—thyroid cancer	0.00012	0.000346	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—PTEN—thyroid cancer	0.000118	0.000339	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—HRAS—thyroid cancer	0.000117	0.000337	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—HPGD—thyroid cancer	0.000113	0.000326	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—AKT1—thyroid cancer	0.000109	0.000314	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—TP53—thyroid cancer	0.000107	0.000308	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—AKT1—thyroid cancer	0.000103	0.000298	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—HRAS—thyroid cancer	0.000102	0.000294	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—PPARG—thyroid cancer	9.26e-05	0.000267	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—AKT1—thyroid cancer	9.03e-05	0.00026	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—PTGS2—thyroid cancer	7.28e-05	0.00021	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—AKT1—thyroid cancer	6.78e-05	0.000195	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—TPR—thyroid cancer	6.49e-05	0.000187	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—PRKAR1A—thyroid cancer	6.39e-05	0.000184	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—PTEN—thyroid cancer	6.35e-05	0.000183	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—SLC5A5—thyroid cancer	4.86e-05	0.00014	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—RXRA—thyroid cancer	4.08e-05	0.000118	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—AKT1—thyroid cancer	3.66e-05	0.000105	CbGpPWpGaD
Niacin—Salicylic acid—PTGS2—thyroid cancer	3.41e-05	1	CrCbGaD
Niacin—CYP2D6—Metabolism—PPARG—thyroid cancer	2.58e-05	7.43e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—PTGS2—thyroid cancer	2.03e-05	5.84e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—PTEN—thyroid cancer	1.77e-05	5.09e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—AKT1—thyroid cancer	1.02e-05	2.94e-05	CbGpPWpGaD
